ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,289, issued on May 13, was assigned to GLYCOTOPE GMBH (Berlin).
"Anti-MUC1 antibody" was invented by Johanna Gellert (Berlin), Anke Flechner (Berlin), Doreen Weigelt (Berlin) and Antje Danielczyk (Berlin).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure pertains to novel antibodies directed against the cancer antigen MUC1. In particular, an antibody with improved antigen binding was obtained by deleting a glycosylation site in the CDR-H2 of a known anti-MUC1 antibody."
The patent was filed on May 17, 2019, under Application No. 17/055,303.
*For further information, including images, charts and tables, please visit: http://patft...